Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Gunn Huh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4502-7568; OpenAlex author ID A5034571654. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. Comparison of clinical features and pancreatic cancer risk between genetic mutations associated versus alcohol associated chronic pancreatitis. Co-author DOI 10.1016/j.pan.2025.10.011↗
  2. Acute pancreatitis as an early sign of pancreatic cancer; a retrospective, matched cohort study. Co-author DOI 10.1080/00365521.2024.2414804↗
  3. Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, p… Co-author DOI 10.1177/17588359211056179↗
  4. Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching … Co-author DOI 10.1186/s12885-021-08277-7↗
  5. Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach. Co-author DOI 10.5306/wjco.v11.i9.747↗
  6. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort. Co-author DOI 10.1002/cam4.2617↗
  7. Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer. Co-author DOI 10.5009/gnl18220↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Woo Hyun Paik · 5 shared papers, 2018–2021 · strength 0.58
  2. Sang Hyub Lee · 5 shared papers, 2018–2021 · strength 0.58
  3. Ji Kon Ryu · 5 shared papers, 2018–2021 · strength 0.58
  4. Yong‐Tae Kim · 5 shared papers, 2018–2021 · strength 0.58
  5. Dong Wan Seo · 2 shared papers, 2024–2026 · strength 0.58
  6. Yoonchan Lee · 2 shared papers, 2024–2026 · strength 0.58
  7. Dongwook Oh · 2 shared papers, 2024–2026 · strength 0.58
  8. Jung Won Chun · 3 shared papers, 2019–2021 · strength 0.36
  9. Tae Jun Song · 1 shared paper, 2026 · strength 0.36
  10. Jin Ho Choi · 3 shared papers, 2018–2021 · strength 0.33
  11. Min Su You · 3 shared papers, 2018–2020 · strength 0.32
  12. Hyehyun Jeong · 1 shared paper, 2024 · strength 0.23
  13. Sung-Hyun Cho · 1 shared paper, 2024 · strength 0.23
  14. Changhoon Yoo · 1 shared paper, 2024 · strength 0.23
  15. In Rae Cho · 1 shared paper, 2021 · strength 0.13
  16. Hee Seung Lee · 1 shared paper, 2021 · strength 0.13
  17. Eaum Seok Lee · 1 shared paper, 2021 · strength 0.13
  18. Seungmin Bang · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.